Page last updated: 2024-10-19

niacin and Apolipoprotein C-II Deficiency

niacin has been researched along with Apolipoprotein C-II Deficiency in 6 studies

Niacin: A water-soluble vitamin of the B complex occurring in various animal and plant tissues. It is required by the body for the formation of coenzymes NAD and NADP. It has PELLAGRA-curative, vasodilating, and antilipemic properties.
vitamin B3 : Any member of a group of vitamers that belong to the chemical structural class called pyridines that exhibit biological activity against vitamin B3 deficiency. Vitamin B3 deficiency causes a condition known as pellagra whose symptoms include depression, dermatitis and diarrhea. The vitamers include nicotinic acid and nicotinamide (and their ionized and salt forms).
nicotinic acid : A pyridinemonocarboxylic acid that is pyridine in which the hydrogen at position 3 is replaced by a carboxy group.

Research Excerpts

ExcerptRelevanceReference
"Niacin was started after recurrence."1.36Case report. Hyperlipoproteinaemia(a): which is the optimal therapy? A case report. ( Lupattelli, G; Mannarino, E; Roscini, AR; Siepi, D, 2010)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19903 (50.00)18.7374
1990's1 (16.67)18.2507
2000's0 (0.00)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brahm, AJ1
Hegele, RA1
Lupattelli, G1
Roscini, AR1
Siepi, D1
Mannarino, E1
FAIVRE, G1
GILGENKRANTZ, JM1
CHERRIER, F1
HENRY, C1
van der Wel, AM1
Castro Cabezas, M1
de Bruin, TW1
Erkelens, DW1
Gotto, AM1
Jones, PH1
Scott, LW1
Schaefer, EJ1
Levy, RI1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Estudio clínico Fase III Para Evaluar la Eficacia terapéutica en Pacientes Mexicanos Con Dislipidemia Mediante el Uso vía Oral de L-Carnitina + Atorvastatina Comparado Con Atorvastatina[NCT03696940]Phase 3120 participants (Actual)Interventional2018-05-28Active, not recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

4 reviews available for niacin and Apolipoprotein C-II Deficiency

ArticleYear
Chylomicronaemia--current diagnosis and future therapies.
    Nature reviews. Endocrinology, 2015, Volume: 11, Issue:6

    Topics: Benzimidazoles; Diet Therapy; Fibric Acids; Genetic Therapy; Humans; Hydroxymethylglutaryl-CoA Reduc

2015
[Triglycerides and atherosclerosis; treatment of hypertriglyceridemia].
    Nederlands tijdschrift voor geneeskunde, 1994, Feb-26, Volume: 138, Issue:9

    Topics: Arteriosclerosis; Chylomicrons; Diet, Reducing; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibito

1994
The diagnosis and management of hyperlipidemia.
    Disease-a-month : DM, 1986, Volume: 32, Issue:5

    Topics: Adolescent; Adult; Child; Child, Preschool; Cholesterol; Cholestyramine Resin; Chylomicrons; Clofibr

1986
Pathogenesis and management of lipoprotein disorders.
    The New England journal of medicine, 1985, May-16, Volume: 312, Issue:20

    Topics: Abetalipoproteinemia; Adolescent; Adult; Aged; Child; Child, Preschool; Cholestyramine Resin; Chylom

1985

Other Studies

2 other studies available for niacin and Apolipoprotein C-II Deficiency

ArticleYear
Case report. Hyperlipoproteinaemia(a): which is the optimal therapy? A case report.
    Journal of clinical pharmacy and therapeutics, 2010, Volume: 35, Issue:5

    Topics: Cholesterol, HDL; Cholesterol, LDL; Clofibric Acid; Fluorobenzenes; Humans; Hydroxymethylglutaryl-Co

2010
[FAMILIAL XANTHOMATOUS HYPERCHOLESTEREMIA].
    Coeur et medecine interne, 1963, Volume: 58

    Topics: Adrenocorticotropic Hormone; Cortisone; Diagnosis, Differential; Diet; Diet Therapy; Dietary Fats; E

1963